Ceridian HCM Holding Inc.

NYSE:CDAY

69.52 (USD) • At close January 31, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 399.7377.5365.9370.6336.1315.6301.2293.3282.1257.2250.4234.5222.8204.4192.6222.7221.8202.3196.3203.7200.3179.6179.3208.9262.3163.5157.5187
Cost of Revenue 229.9217210210.3201196.6185.2190.2178.2164.1158.3141.3137.3127.7114122.2124113.5108.3110.1108.8104.6106.5119.7154.1102.299.8113.2
Gross Profit 169.8160.5155.9160.3135.1119116103.1103.993.192.193.285.576.778.6100.597.888.88893.691.57572.889.2108.261.357.773.8
Gross Profit Ratio 0.4250.4250.4260.4330.4020.3770.3850.3520.3680.3620.3680.3970.3840.3750.4080.4510.4410.4390.4480.4590.4570.4180.4060.4270.4130.3750.3660.395
Reseach & Development Expenses 56.453.349.251130.144.839.840.413436.631.825.883.722.91717.667.917.516.415.25914.515.115.40000
General & Administrative Expenses 58.30067.7247.560.100000074.6074.60000000000000
Selling & Marketing Expenses 72.70054.2251.562.600000032.8000000000000000
SG&A 131134126.5121.9131.8122.7122.5122101.3109.1111.895.6107.477.374.674.278.182.369.366.270.459.484.165.69252.454.860.7
Other Expenses 5.6-5.1-0.7-51-130.1-44.8-39.80.3-2.7-3.4-8.2-4.600.2-0.3-2.6-0.9-1.6-1.5-1.62.50.30-2.8-6.93.820.9
Operating Expenses 187.4134126.5121.9131.8122.7122.5122101.3109.1111.895.6107.477.374.674.278.182.369.366.272.959.784.162.885.156.256.861.6
Operating Income 38.826.529.438.4-18.4-9.6-12.3-18.62.616-19.7-2.4-21.9-0.6426.319.7-6.518.727.421.515.311.326.423.15.10.912.2
Operating Income Ratio 0.0970.070.080.104-0.055-0.03-0.041-0.0630.0090.062-0.079-0.01-0.098-0.0030.0210.1180.089-0.0320.0950.1350.1070.0850.0630.1260.0880.0310.0060.065
Total Other Income Expenses Net -3.3-14-9.8-10-5.8-19.4-12.5-6.3-2.5-13.4-18.1-10.2-5.7-5.7-6.9-9.5-8.1-9.4-10-10.5-8.8-8.8-43.4-25.1-29.2-21.9-22-21.4
Income Before Tax 35.512.519.628.4-2.5-17-19-24.4-10.5-29.4-37.8-12.6-27.6-6.3-2.916.811.6-2.98.716.912.76.5-54.74.2-6.1-16.8-21.1-9.2
Income Before Tax Ratio 0.0890.0330.0540.077-0.007-0.054-0.063-0.083-0.037-0.114-0.151-0.054-0.124-0.031-0.0150.0750.052-0.0140.0440.0830.0630.036-0.3050.02-0.023-0.103-0.134-0.049
Income Tax Expense -10.116.316.518.52.740.83-1-8.5-126.6-10.3-5.5-8.48.213.1-65.62.45.71.9-0.91.16.8-48.50.91.92.5
Net Income 45.6-3.83.19.9-5.2-21-19.8-27.4-9.5-20.9-25.8-19.2-17.3-0.85.58.6-1.562.76.311.2-0.24.4-65.5-2.145-20.1-22.9-11.2
Net Income Ratio 0.114-0.010.0080.027-0.015-0.067-0.066-0.093-0.034-0.081-0.103-0.082-0.078-0.0040.0290.039-0.0070.310.0320.055-0.0010.024-0.365-0.010.172-0.123-0.145-0.06
EPS 0.29-0.0240.020.06-0.034-0.14-0.13-0.18-0.063-0.14-0.17-0.13-0.12-0.0050.0380.06-0.010.440.0450.08-0.0010.032-0.58-0.0160.69-0.31-0.35-0.17
EPS Diluted 0.29-0.0240.020.06-0.034-0.14-0.13-0.18-0.063-0.14-0.17-0.13-0.12-0.0050.0360.057-0.010.420.0430.076-0.0010.03-0.58-0.0160.69-0.15-0.17-0.17
EBITDA 27.960.143.759.730.412.39.32.310.21.6-4.68-21.912.615.835.511.319.831.840.235.729.61.941.333.918.712.926.3
EBITDA Ratio 0.160.1590.1420.1610.0180.0390.0310.008-00.006-0.0180.034-0.0980.0620.0820.1590.0850.0980.1620.1970.1780.1650.0110.1980.1290.1140.0820.141